The Efficacy and Safety of Chlorhexidine Gluconate Chip (PerioChip®) in Therapy of Peri-implantitis

PHASE3CompletedINTERVENTIONAL
Enrollment

290

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

October 31, 2018

Study Completion Date

November 30, 2018

Conditions
Peri-Implantitis
Interventions
DRUG

2.5 mg Chlorhexidine gluconate chip

Subgingival debridement will be carried out for each one of the target implant. Upon completion of the debridement a PerioChip® will be inserted in each one of the target implant.

Trial Locations (10)

9602

Department of Periodontology, School of Graduate Dentistry, Rambam Health Care Center, Haifa

10032

Columbia University, College of Dental Medicine ,Division of Periodontics, New York

35392

Zentrum für Zahn,- Mund- und Kieferheilkunde Poliklinik für Parodontologie, Giessen

Unknown

University of Maryland, School of Dentistry, Department of Periodontics, Baltimore

Tufts University, School of Dental Medicine, Department of Oral Medicine, Boston

University of Michigan, School of Dentistry, Department of Periodontics and Oral Medicine, Ann Arbor

The Faculty of Dental Medicine, Department of Periodontics, Hadassah Ein Karem, Jerusalem

Institute of Dentistry, Barts & The London School of Medicine & Dentistry, Queen Mary University of London (QMUL), London

02115

The Harvard School of Dental Medicine, Boston

11794-8700

Stony Brook University, School of Dental Medicine, Department of Periodontology, Stony Brook

All Listed Sponsors
lead

Dexcel Pharma Technologies Ltd.

INDUSTRY

NCT02080403 - The Efficacy and Safety of Chlorhexidine Gluconate Chip (PerioChip®) in Therapy of Peri-implantitis | Biotech Hunter | Biotech Hunter